Kato S, Tsujimoto S-I, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N. Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i&gt;. haematol [Internet]. 2020Sep.10 [cited 2024Nov.19];. Available from: https://haematologica.org/article/view/haematol.2024.286243